These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2840630)

  • 1. Prophylactic and therapeutic use of immunoglobulin for intravenous administration in patients with secondary immunodeficiencies associated with malignancies.
    Morell A; Barandun S
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S87-91. PubMed ID: 2840630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of intravenous immune globulin in multiple myeloma.
    Chapel HM; Lee M
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):21-4. PubMed ID: 8033429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic intervention of clinical sepsis with intravenous immunoglobulin, white blood cells and antibiotics.
    Fischer GW; Weisman LE
    Scand J Infect Dis Suppl; 1990; 73():17-21. PubMed ID: 2128662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study.
    Molica S; Musto P; Chiurazzi F; Specchia G; Brugiatelli M; Cicoira L; Levato D; Nobile F; Carotenuto M; Liso V; Rotoli B
    Haematologica; 1996; 81(2):121-6. PubMed ID: 8641639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravenous immunoglobulins: anti-infection indications].
    Mouthon L; Guillevin L
    Ann Med Interne (Paris); 2000 Mar; 151(2):136-43. PubMed ID: 10855366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoglobulin administration as infection prevention in oncologic patients].
    Bode U; Erps M; Liappis N
    Klin Padiatr; 1986; 198(6):476-8. PubMed ID: 3468302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenous immunoglobulins in the prevention of infection in children with hematologic-oncologic diseases].
    Lehrnbecher T
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A103-5. PubMed ID: 11577369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-marketing observational study on 5% intravenous immunoglobulin therapy in patients with secondary immunodeficiency and recurrent serious bacterial infections.
    Günther G; Dreger B
    Microbiol Immunol; 2013 Jul; 57(7):527-35. PubMed ID: 23607863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of gamma globulin.
    Berger M; Gilbert I
    Semin Respir Infect; 1989 Dec; 4(4):272-83. PubMed ID: 2516639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of 7S immunoglobulin substitution on the incidence and course of infection in cytostatic drug treated patients].
    Hadjilaskari P; Roehrig G; Hartmann R; Fengler R; Henze G
    Klin Padiatr; 1990; 202(4):275-7. PubMed ID: 2395313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.
    Fischer GW
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preventive and therapeutic use of intravenous administration of immunoglobulins in intensive care patients in pediatrics].
    Leititis JU
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():29-34. PubMed ID: 8499748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin: a review.
    Eibl MM; Wedgwood RJ
    Immunodefic Rev; 1989; 1 Suppl():1-42. PubMed ID: 2698646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic intravenous immunoglobulin during autologous haemopoietic stem cell transplantation for multiple myeloma is not associated with reduced infectious complications.
    Blombery P; Prince HM; Worth LJ; Main J; Yang M; Wood EM; Westerman DA
    Ann Hematol; 2011 Oct; 90(10):1167-72. PubMed ID: 21674144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New aspects of therapy with standard immunoglobulin preparations].
    Briese V
    Zentralbl Gynakol; 1986; 108(21):1273-81. PubMed ID: 3811676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunoglobulin substitution in malignant lymphoma].
    Wehmeier A
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():73-6; discussion 77. PubMed ID: 8499755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravenous administration of immunoglobulin preparations in clinical practice ( review of foreign literature)].
    Sharygin SL; Sapozhnikova VS
    Klin Med (Mosk); 1991 Jul; 69(7):20-3. PubMed ID: 1719271
    [No Abstract]   [Full Text] [Related]  

  • 19. High-dose intravenous immunoglobulin treatment of multiple sclerosis.
    Durelli L; Isoardo G
    Neurol Sci; 2002 Apr; 23 Suppl 1():S39-48. PubMed ID: 12032586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immune globulin in chronic lymphocytic leukaemia.
    Gamm H; Huber C; Chapel H; Lee M; Ries F; Dicato MA
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):17-20. PubMed ID: 8033428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.